E

Exact Sciences Corp
D

EXAS

44.420
USD
-1.06
(-2.33%)
مفتوح الان
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
8,259,614,128
أصول ذات صلة
ABBV
ABBV
-14.500
(-7.69%)
173.600 USD
BAX
BAX
-2.440
(-7.93%)
28.340 USD
BDX
BDX
-6.870
(-3.33%)
199.170 USD
BSX
BSX
2.820
(3.14%)
92.640 USD
GILD
GILD
-2.845
(-2.71%)
102.240 USD
ILMN
ILMN
-2.490
(-3.38%)
71.160 USD
MDT
MDT
-0.650
(-0.78%)
82.540 USD
M
MYGN
0.05500
(0.70%)
7.96500 USD
SYK
SYK
2.30
(0.66%)
349.16 USD
T
TNDM
0.680
(4.15%)
17.070 USD
VRTX
VRTX
-1.07
(-0.22%)
474.48 USD
المزيد
الأخبار المقالات

العنوان: Exact Sciences Corp

القطاع: Healthcare
الصناعة: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, aliquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.